{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T05:08:00Z","timestamp":1773378480284,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T00:00:00Z","timestamp":1765670400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T00:00:00Z","timestamp":1765670400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004897","name":"European Organisation for Research and Treatment of Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1245\/s10434-025-18833-1","type":"journal-article","created":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T16:28:18Z","timestamp":1765729698000},"page":"3293-3301","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The Value of Ultrasound in Patients with T1\u2013T2 Breast Cancer with No Palpable Lymph Nodes Enrolled in the EORTC 10981\u201322023 AMAROS Trial"],"prefix":"10.1245","volume":"33","author":[{"given":"A. W. J.","family":"Beerthuizen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. I. M.","family":"Snellen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. A.","family":"Bartels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Kuijer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Poncet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. A.","family":"Drukker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. J. T.","family":"Rutgers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. J. T. F. D. Vrancken","family":"Peeters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. H.","family":"van Duijnhoven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,14]]},"reference":[{"issue":"4","key":"18833_CR1","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s13244-018-0636-z","volume":"9","author":"A Evans","year":"2018","unstructured":"Evans A, Trimboli RM, Athanasiou A, et al. Breast ultrasound: recommendations for information to women and referring physicians by the European society of breast imaging. Insights Imaging. 2018;9(4):449\u201361. https:\/\/doi.org\/10.1007\/s13244-018-0636-z.","journal-title":"Insights Imaging"},{"key":"18833_CR2","doi-asserted-by":"publisher","first-page":"109468","DOI":"10.1016\/j.ejrad.2020.109468","volume":"135","author":"F Riedel","year":"2021","unstructured":"Riedel F, Schaefgen B, Sinn HP, et al. Diagnostic accuracy of axillary staging by ultrasound in early breast cancer patients. Eur J Radiol. 2021;135:109468. https:\/\/doi.org\/10.1016\/j.ejrad.2020.109468.","journal-title":"Eur J Radiol."},{"key":"18833_CR3","unstructured":"NCCN Clinical practice guidelines in oncology (NCCN Guidelines\u00ae). Breast Cancer. Version 4.2022\u2013June 21, 2022. www.NCCN.org"},{"issue":"1","key":"18833_CR4","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s00268-012-1788-5","volume":"37","author":"S Majid","year":"2013","unstructured":"Majid S, Tengrup I, Manjer J. Clinical assessment of axillary lymph nodes and tumor size in breast cancer compared with histopathological examination: a population-based analysis of 2,537 women. World J Surg. 2013;37(1):67\u201371. https:\/\/doi.org\/10.1007\/s00268-012-1788-5.","journal-title":"World J Surg."},{"issue":"3","key":"18833_CR5","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s10549-015-3280-z","volume":"149","author":"Y Feng","year":"2015","unstructured":"Feng Y, Huang R, He Y, et al. Efficacy of physical examination, ultrasound, and ultrasound combined with fine-needle aspiration for axilla staging of primary breast cancer. Breast Cancer Res Treat. 2015;149(3):761\u20135. https:\/\/doi.org\/10.1007\/s10549-015-3280-z.","journal-title":"Breast Cancer Res Treat."},{"issue":"12","key":"18833_CR6","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","volume":"15","author":"M Donker","year":"2014","unstructured":"Donker M, van Tienhoven G, Straver ME, et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981\u201322023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncol. 2014;15(12):1303\u201310. https:\/\/doi.org\/10.1016\/S1470-2045(14)70460-7.","journal-title":"Lancet Oncol"},{"issue":"12","key":"18833_CR7","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1200\/JCO.22.01565","volume":"41","author":"SAL Bartels","year":"2023","unstructured":"Bartels SAL, Donker M, Poncet C, et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer: 10-year results of the randomized controlled EORTC 10981\u201322023 AMAROS trial. J Clin Oncol. 2023;41(12):2159\u201365. https:\/\/doi.org\/10.1200\/JCO.22.01565.","journal-title":"J Clin Oncol."},{"issue":"5","key":"18833_CR8","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1093\/annonc\/mdv106","volume":"26","author":"S Gourgou-Bourgade","year":"2015","unstructured":"Gourgou-Bourgade S, Cameron D, Poortmans P, et al. Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (definition for the assessment of time-to-event endpoints in cancer trials)dagger. Ann Oncol. 2015;26(5):873\u20139. https:\/\/doi.org\/10.1093\/annonc\/mdv106.","journal-title":"Ann Oncol."},{"issue":"11","key":"18833_CR9","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1056\/NEJMoa2412063","volume":"392","author":"T Reimer","year":"2025","unstructured":"Reimer T, Stachs A, Veselinovic K, et al. Axillary surgery in breast cancer\u2013primary results of the INSEMA Trial. N Engl J Med. 2025;392(11):1051\u201364. https:\/\/doi.org\/10.1056\/NEJMoa2412063.","journal-title":"N Engl J Med."},{"issue":"8","key":"18833_CR10","doi-asserted-by":"publisher","first-page":"4764","DOI":"10.1245\/s10434-022-11829-1","volume":"29","author":"JC Radosa","year":"2022","unstructured":"Radosa JC, Solomayer EF, Deeken M, et al. Preoperative sonographic prediction of limited axillary disease in patients with primary breast cancer meeting the Z0011 criteria: An Alternative to sentinel node biopsy? Ann Surg Oncol. 2022;29(8):4764\u201372. https:\/\/doi.org\/10.1245\/s10434-022-11829-1.","journal-title":"Ann Surg Oncol."},{"issue":"2","key":"18833_CR11","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s10549-022-06677-2","volume":"195","author":"A Weiss","year":"2022","unstructured":"Weiss A, King C, Vincuilla J, et al. Rates of pathologic nodal disease among cN0 and cN1 patients undergoing routine axillary ultrasound and neoadjuvant chemotherapy. Breast Cancer Res Treat. 2022;195(2):181\u20139. https:\/\/doi.org\/10.1007\/s10549-022-06677-2.","journal-title":"Breast Cancer Res Treat."},{"key":"18833_CR12","doi-asserted-by":"publisher","first-page":"111775","DOI":"10.1016\/j.ejrad.2024.111775","volume":"181","author":"TJA van Nijnatten","year":"2024","unstructured":"van Nijnatten TJA, Poplack SP, Wijgers RA, et al. Differences in axillary ultrasound protocols among prospective de-escalating axillary surgical staging trials in clinically node negative early breast cancer patients. Eur J Radiol. 2024;181:111775. https:\/\/doi.org\/10.1016\/j.ejrad.2024.111775.","journal-title":"Eur J Radiol."},{"issue":"11","key":"18833_CR13","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1001\/jamaoncol.2023.3759","volume":"9","author":"OD Gentilini","year":"2023","unstructured":"Gentilini OD, Botteri E, Sangalli C, et al. Sentinel lymph node biopsy vs no axillary surgery in patients with small breast cancer and negative results on ultrasonography of axillary lymph nodes: the SOUND randomized clinical trial. JAMA Oncol. 2023;9(11):1557\u201364. https:\/\/doi.org\/10.1001\/jamaoncol.2023.3759.","journal-title":"JAMA Oncol."},{"issue":"22","key":"18833_CR14","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1200\/JCO.19.00066","volume":"37","author":"SM Tolaney","year":"2019","unstructured":"Tolaney SM, Guo H, Pernas S, et al. Seven-year follow-up analysis of adjuvant paclitaxel and trastuzumab trial for node-negative, human epidermal growth factor receptor 2-positive breast cancer. J Clin Oncol. 2019;37(22):1868\u201375. https:\/\/doi.org\/10.1200\/JCO.19.00066.","journal-title":"J Clin Oncol."},{"issue":"21","key":"18833_CR15","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1056\/NEJMoa2409932","volume":"391","author":"P Schmid","year":"2024","unstructured":"Schmid P, Cortes J, Dent R, et al. Overall survival with pembrolizumab in early-stage triple-negative breast cancer. N Engl J Med. 2024;391(21):1981\u201391. https:\/\/doi.org\/10.1056\/NEJMoa2409932.","journal-title":"N Engl J Med."},{"issue":"7","key":"18833_CR16","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1056\/NEJMoa1814017","volume":"380","author":"G von Minckwitz","year":"2019","unstructured":"von Minckwitz G, Huang CS, Mano MS, et al. Trastuzumab emtansine for residual invasive HER2-positive breast cancer. N Engl J Med. 2019;380(7):617\u201328. https:\/\/doi.org\/10.1056\/NEJMoa1814017.","journal-title":"N Engl J Med."},{"issue":"22","key":"18833_CR17","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1056\/NEJMoa1612645","volume":"376","author":"N Masuda","year":"2017","unstructured":"Masuda N, Lee SJ, Ohtani S, et al. Adjuvant capecitabine for breast cancer after preoperative chemotherapy. N Engl J Med. 2017;376(22):2147\u201359. https:\/\/doi.org\/10.1056\/NEJMoa1612645.","journal-title":"N Engl J Med."},{"key":"18833_CR18","doi-asserted-by":"publisher","first-page":"115607","DOI":"10.1016\/j.ejca.2025.115607","volume":"226","author":"R Di Micco","year":"2025","unstructured":"Di Micco R, Hartmann S, Banys-Paluchowski M, et al. Diagnostic performance of axillary ultrasound after neoadjuvant chemotherapy in initially node-positive breast cancer patients\u2013results from the prospective AXSANA registry trial. Eur J Cancer. 2025;226:115607. https:\/\/doi.org\/10.1016\/j.ejca.2025.115607.","journal-title":"Eur J Cancer."},{"key":"18833_CR19","doi-asserted-by":"publisher","DOI":"10.1200\/JCO-25-00099","author":"KU Park","year":"2025","unstructured":"Park KU, Somerfield MR, Anne N, et al. Sentinel lymph node biopsy in early-stage breast cancer: ASCO guideline update. J Clin Oncol. 2025. https:\/\/doi.org\/10.1200\/JCO-25-00099.","journal-title":"J Clin Oncol."},{"key":"18833_CR20","doi-asserted-by":"publisher","DOI":"10.1200\/JCO-25-01630","author":"A Kaviani","year":"2025","unstructured":"Kaviani A, Bourque JM, Farazmand B, Salmon RJ. Beyond the trials: real-world considerations for sentinel lymph node biopsy omission in early breast cancer. J Clin Oncol. 2025. https:\/\/doi.org\/10.1200\/JCO-25-01630.","journal-title":"J Clin Oncol."},{"issue":"2","key":"18833_CR21","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.jamcollsurg.2015.11.013","volume":"222","author":"M Pilewskie","year":"2016","unstructured":"Pilewskie M, Jochelson M, Gooch JC, Patil S, Stempel M, Morrow M. Is preoperative axillary imaging beneficial in identifying clinically node-negative patients requiring axillary lymph node dissection? J Am Coll Surg. 2016;222(2):138\u201345. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2015.11.013.","journal-title":"J Am Coll Surg."},{"issue":"10","key":"18833_CR22","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1001\/jama.2017.11470","volume":"318","author":"AE Giuliano","year":"2017","unstructured":"Giuliano AE, Ballman KV, McCall L, et al. Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial. JAMA. 2017;318(10):918\u201326. https:\/\/doi.org\/10.1001\/jama.2017.11470.","journal-title":"JAMA"},{"key":"18833_CR23","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.amjsurg.2024.03.011","volume":"231","author":"K Jiang","year":"2024","unstructured":"Jiang K, Ma C, Yang Y, et al. Axillary ultrasonography for early-stage invasive breast cancer. Am J Surg. 2024;231:86\u201390. https:\/\/doi.org\/10.1016\/j.amjsurg.2024.03.011.","journal-title":"Am J Surg."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18833-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-18833-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18833-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T15:48:03Z","timestamp":1773330483000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-18833-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,14]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["18833"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-18833-1","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,14]]},"assertion":[{"value":"10 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This trial was sponsored by the EORTC with financial support from the Kankerbestrijding\/KWF from the Netherlands through the EORTC Cancer Research Fund (ECRF). We did not receive any other grants from funding agencies in the public, commercial, or not-for-profit sectors.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}